The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status
- Resource Type
- Article
- Source
- In
Clinical Colorectal Cancer 2011 10(4):333-339 - Subject
- Language
- ISSN
- 1533-0028